Sign In
Buy BLU
$14.74
+0 (+0%)
At Close: Sep 27, 2023
Bellus Health (BLU) Reports Q2 Loss, Lags Revenue Estimates
07:55pm, Thursday, 13'th Aug 2020
Bellus (BLU) delivered earnings and revenue surprises of 26.32% and -42.86%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
BELLUS Health Reports Second Quarter 2020 Financial Results and Business Highlights
11:00am, Thursday, 13'th Aug 2020
BELLUS Health Inc. (Nasdaq:BLU; TSX:BLU) ("BELLUS Health" or the "Company"), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of chronic cough and other hyper
Bellus Health (BLU) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
04:30pm, Thursday, 06'th Aug 2020
Bellus (BLU) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BOSTON, July 19, 2020 -- Block & Leviton LLP (www.blockesq.com), a national securities litigation firm, reminds investors that it is investigating the following companies.
Bellus Health: AstraZeneca Owns Shares, But The Market Does Not Notice It
08:58am, Tuesday, 14'th Jul 2020
BELLUS Health develops treatments for chronic cough, hypersensitization disorders, and chronic pruritus or chronic itch.
LOS ANGELES, CA / ACCESSWIRE / July 13, 2020 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of BELLUS Health Inc
LOS ANGELES, CA / ACCESSWIRE / July 10, 2020 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of BELLUS Health Inc
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of BELLUS Health Inc. ("BELLUS" or "the Company") (NASDAQ: BLU). Investors who purc
LOS ANGELES, CA / ACCESSWIRE / July 9, 2020 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of BELLUS Health Inc
SAN FRANCISCO, July 09, 2020 -- Hagens Berman urges investors in BELLUS Health Inc. (NASDAQ: BLU) to submit their losses now. The firm is investigating possible violations of.
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against BELLUS Health Inc.
Trade Alert: The Chairman of the Board Of BELLUS Health Inc. (TSE:BLU), Francesco Bellini, Has Just Spent US$390k Buying 31% More Shares
10:01am, Thursday, 09'th Jul 2020
Investors who take an interest in BELLUS Health Inc. (TSE:BLU) should definitely note that the Chairman of the Board...
SHAREHOLDER ALERT: Investigation of BELLUS Health Announced by Holzer & Holzer, LLC
07:18pm, Wednesday, 08'th Jul 2020
Holzer investigates BELLUS Health
BOSTON, MA / ACCESSWIRE / July 8, 2020 / Block & Leviton LLP ( www.blockesq.com ), a national securities litigation firm, is investigating whether BELLUS Health, Inc. (NASDAQ:BLU) and certain of its e
Bellus Health Craters 72% On Chronic Cough Miss; Analyst Still Says Buy
09:41am, Tuesday, 07'th Jul 2020
Shares in biopharma Bellus Health (BLU) cratered 72% in Monday’s trading, after the company announced disappointing topline results from its Phase 2 RELIEF trial of BLU-5937 in patients with refract
